Will the recent momentum be cut short following the biotech's Feb. 10 earnings release, or will it continue?
StockStory.org on MSN
Exact Sciences (EXAS): Buy, sell, or hold post Q3 earnings?
What a time it’s been for Exact Sciences. In the past six months alone, the company’s stock price has increased by a massive ...
They work inside integrated development environments (IDEs), where code, documentation, testing, version history and ...
New peptide research blend shows promise as a game-changer in the fitness space BURTON, MI, UNITED STATES, January 19, ...
The new facility will cost $137 million and will house 18 research labs, four teaching labs, a 300-seat lecture hall, and ...
Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA.
Achieve Life Sciences is a late-stage pharma company awaiting FDA approval for Cytisinicline, a novel smoking cessation ...
Many organizations are operating with constrained resources while trying to expand, launch new therapies, or scale ...
Airflow Sciences Corporation has been awarded $1.15 Million from the U.S. Department of Energy to develop a specialized ...
Dr. Cindi Love, Executive Director of Out for Undergrad, emphasized the significance of Valladares’ appointment: ...
A professor and chair of UAMS’ Department of Orthopaedic Surgery, C. Lowry Barnes was selected as one of four finalists in a ...
The new St. Luke’s College of Health Sciences is kicking off its inaugural semester. In this Community Connection, Rebecca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results